CD8A and neoplasm: Although no individual T cell surface marker is an accurate predictor of tumour-antigen specificity, multiple studies suggest that expression of multiple IhRs such as PD-1, LAG-3, TIM-3, the integrin protein CD103 and oligoclonality of CD8+ T cells are associated with tumour-specificity [40].